Do SGLT2 Inhibitors Impact Fractures in Diabetic Kidney Disease? Do SGLT2 Inhibitors Impact Fractures in Diabetic Kidney Disease?
Study provides real-world assurance that SGLT2 inhibitors have no added risk of fracture in patients with mainly mild kidney disease after a year of use. But follow-up was short, say experts.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Drugs & Pharmacology | Endocrinology | SGLT2 Inhibitors | Study | Urology & Nephrology